AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (August 31, 2007). doi:10.1152/ajpheart.00587.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/H3150    most recent
00587.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Gray, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Gray, M. O.
Submitted on June 5, 2006
Accepted on August 30, 2007

Signals from Type 1 Sphingosine 1-Phosphate Receptors Enhance Adult Mouse Cardiac Myocyte Survival During Hypoxia

Jianqing Zhang1, Norman Honbo1, Edward J. Goetzl2, Kanu Chatterjee3, Joel S Karliner4, and Mary O. Gray3*

1 Cardiology Section, San Francisco VA Medical Center, San Francisco, California, United States
2 Departments of Medicine and Microbiology-Immunology, UC San Francisco, San Francisco, California, United States
3 Department of Medicine, UC San Francisco, San Francisco, California, United States
4 Cardiology Section, San Francisco VA Medical Center, San Francisco, California, United States; Department of Medicine, UC San Francisco, San Francisco, California, United States

* To whom correspondence should be addressed. E-mail: mgray{at}medsfgh.ucsf.edu.

Sphingosine 1-phosphate (S1P) is a biologically active lysophospholipid that serves as a key regulator of cellular differentiation and survival. Immune stimuli increase S1P synthesis and secretion by mast cells and platelets, implicating this molecule in tissue responses to injury and inflammation. Binding of S1P to Gi protein-coupled receptors activates phosphatidylinositol 3-kinase and Akt in a variety of tissues. To elucidate the mechanisms by which S1P enhances adult cardiac myocyte survival during hypoxia, we used a mouse cell culture system in which S1P1 receptors were observed to transduce signals from exogenous S1P, an S1P1 receptor antibody with agonist properties, and the pharmacological agents FTY720 and SEW2871. S1P1 receptor mRNA and protein were abundantly expressed by adult mouse cardiac myocytes. S1P-S1P1 receptor axis enhancement of myocyte survival during hypoxia was abolished by phosphatidylinositol 3-kinase inhibition. S1P-S1P1 receptor function was closely associated with activation of Akt, inactivation of GSK-3{beta}, and reduction of cytochrome c release from heart mitochondria. These observations highlight the importance of S1P-S1P1 receptors on ventricular myocytes as mediators of inducible resistance against cellular injury during severe hypoxic stress.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Vessey, L. Li, N. Honbo, and J. S. Karliner
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1429 - H1435.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A. Frias, U. Lang, C. Gerber-Wicht, and R. W. James
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis
Cardiovasc Res, September 18, 2009; (2009) cvp289v2.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Hofmann, N. Burkard, C. Vogt, A. Thoma, S. Frantz, G. Ertl, O. Ritter, and A. Bonz
Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion
Cardiovasc Res, July 15, 2009; 83(2): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. S. Karliner
Sphingosine kinase regulation and cardioprotection
Cardiovasc Res, May 1, 2009; 82(2): 184 - 192.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A. Frias, R. W. James, C. Gerber-Wicht, and U. Lang
Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: Role of sphingosine-1-phosphate
Cardiovasc Res, May 1, 2009; 82(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. K. Means and J. H. Brown
Sphingosine-1-phosphate receptor signalling in the heart
Cardiovasc Res, May 1, 2009; 82(2): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-C. Yeh, H. Li, D. Malhotra, M.-C. Huang, B.-Q. Zhu, E. J. Goetzl, D. A. Vessey, J. S. Karliner, and M. J. Mann
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1193 - H1199.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
X. Ye
Lysophospholipid signaling in the function and pathology of the reproductive system
Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z.-Q. Jin, J. S. Karliner, and D. A. Vessey
Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation
Cardiovasc Res, July 1, 2008; 79(1): 134 - 140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.